Ratios Reveal: Breaking Down Esperion Therapeutics Inc. (ESPR)’s Financial Health

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Esperion Therapeutics Inc. (NASDAQ: ESPR) closed the day trading at $1.76 down -0.56% from the previous closing price of $1.77. In other words, the price has decreased by -$0.56 from its previous closing price. On the day, 3.68 million shares were traded. ESPR stock price reached its highest trading level at $1.8051 during the session, while it also had its lowest trading level at $1.73.

Ratios:

For a better understanding of ESPR, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.49 and its Current Ratio is at 1.97.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 ’24 when Warren Eric sold 211 shares for $1.95 per share. The transaction valued at 411 led to the insider holds 165,267 shares of the business.

Warren Eric bought 211 shares of ESPR for $410 on Aug 19 ’24. On Jul 17 ’24, another insider, Warren Eric, who serves as the Chief Commercial Officer of the company, sold 108 shares for $2.59 each. As a result, the insider received 279 and left with 165,478 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ESPR now has a Market Capitalization of 348307520 and an Enterprise Value of 425186464. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.24. Its current Enterprise Value per Revenue stands at 1.531 whereas that against EBITDA is 85.208.

Stock Price History:

Over the past 52 weeks, ESPR has reached a high of $3.40, while it has fallen to a 52-week low of $0.70. The 50-Day Moving Average of the stock is -22.14%, while the 200-Day Moving Average is calculated to be -20.30%.

Shares Statistics:

Over the past 3-months, ESPR traded about 7.07M shares per day on average, while over the past 10 days, ESPR traded about 4367170 shares per day. A total of 196.22M shares are outstanding, with a floating share count of 194.07M. Insiders hold about 1.10% of the company’s shares, while institutions hold 72.42% stake in the company. Shares short for ESPR as of 1722384000 were 38135175 with a Short Ratio of 5.40, compared to 1719532800 on 23549800. Therefore, it implies a Short% of Shares Outstanding of 38135175 and a Short% of Float of 20.18.

Most Popular